Financial Performance - In Q4 2025, the company reported a net sales of €32.7 billion and a net profit of €9.6 billion, both reaching historical highs [1] - The order intake for Q4 was €13.158 billion, with EUV orders accounting for €7.4 billion, and the order backlog reached €38.8 billion, significantly exceeding market expectations [1] - The company projects net sales for 2026 to be between €34 billion and €39 billion, with a gross margin maintained in the range of 51% to 53% [1] Stock Performance - As of February 10, 2026, the company's stock price was $1,413.62, with a 5-day change of 1.38% and a 20-day change of 10.45% [2] - On February 6, the stock experienced a single-day increase of 4.66% following the positive earnings report, but saw a slight decline of 0.98% on February 10, indicating a market reaction to growth expectations [2] - The trading volume reached $8.493 billion, reflecting a positive market sentiment towards the company's growth prospects [2] Institutional Insights - Analysts noted that the company has a solid competitive moat in 2026, with advancements in High-NA EUV technology commercialization [3] - The strong EUV orders and growth in installation service revenue support the long-term outlook, although there are concerns regarding geopolitical risks and cost pressures associated with High-NA equipment [3] Recent Developments - On February 9, 2026, the Belgian Microelectronics Research Center launched a €2.5 billion chip pilot line, with the company being the largest private investor involved [4] - The high numerical aperture extreme ultraviolet lithography machine is expected to be delivered in March, aimed at enhancing semiconductor R&D capabilities in Europe [4]